J. Cortés

机构：Institut Barcelona d'Estudis Internacionals, Hospital Quirónsalud Barcelona, Molecular Oncology (United States), International Breast Cancer Study Group, Universidad Europea de Madrid

发表论文 29 篇 · 总被引 230 次 · h-index 7

代表论文

• IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer (2024 · Annals of Oncology · 被引 59)
• LBA21 First-line (1L) datopotamab deruxtecan (Dato-DXd) vs chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (mTNBC) for whom immunotherapy was not an option: Primary results from the randomised, phase III TROPION-Breast02 trial (2025 · Annals of Oncology · 被引 26)
• LBA19 Capivasertib (C) + paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): The CAPItello-290 phase III trial (2024 · Annals of Oncology · 被引 10)
• 267MO Pooled analysis of trastuzumab deruxtecan (T-DXd) retreatment (RTx) after recovery from grade (Gr) 1 interstitial lung disease/pneumonitis (ILD) (2024 · ESMO Open · 被引 7)
• Abstract RF7-01: Elacestrant in combination with everolimus or abemaciclib in patients with ER+/HER2- locally advanced or metastatic breast cancer (mBC): phase 2 results from ELEVATE, an open-label, umbrella study (2026 · Clinical Cancer Research · 被引 5)
• Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial (2025 · ESMO Open · 被引 5)